top of page

Talking transfer RNA for cancer and the biotech ecosystem for startups with Cloverleaf Bio's Austin Draycott

He describes how Cloverleaf believes it is different from other tRNA companies and how it has already at the earliest stages benefitted from support of the biotech community.





Comentários


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page